Skip to main content
. 2020 Sep 1;13(9):228. doi: 10.3390/ph13090228
ACE2 angiotensin-converting enzyme 2;
CCHFV Crimean–Congo hemorrhagic fever virus;
CHIKV Chikungunya virus;
DENV Dengue virus;
DTC dithiocarbamate;
EAV equine arteritis virus;
EBOV Ebola virus;
EC50 effective statistically calculated concentration that induces a specific effect in 50% of experimental population under direct/specific conditions;
FCoV feline coronavirus;
FIP feline infectious peritonitis;
FIPV feline infectious peritonitis virus;
FMDV foot-and-mouth disease virus;
HA hemagglutinin;
HAV hepatitis A;
HBsAg Hepatitis B surface antigen (HBsAg),
HBeAg Hepatitis B antigen;
HBV hepatitis B;
HCQ hydroxychloroquine;
HCV hepatitis C;
HIF-1 hypoxia-inducible factor-1;
HIV human immunodeficiency virus;
HK hinokitol;
HSV herpes simplex virus;
IC50 inhibitory concentration: median value of inhibitor, where 50% of biological and biochemical function of organism inhibition is observed;
JEV Japanese encephalitis virus;
NiRAN nidovirus RdRp-associated nucleotidyltransferase;
NTP nucleoside triphosphate;
PDTC pyrrolidine dithiocarbamate;
PRRSV porcine reproductive and respiratory syndrome virus;
PT pyrithione;
RdRp RNA-dependent RNA polymerase;
SARS-CoV respiratory syndrome coronavirus;
SOD superoxide dismutase-1;
UPS ubiquitin-proteasome system;
ZIKV Zika virus